Sex and Body Mass Index differences in the incidence of vascular and cardiometabolic diseases: A retrospective cohort study including 233 730 patients in Germany.
{"title":"Sex and Body Mass Index differences in the incidence of vascular and cardiometabolic diseases: A retrospective cohort study including 233 730 patients in Germany.","authors":"Ximena Orozco-Ruiz, Karel Kostev","doi":"10.1111/dom.70104","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>To examine the association between elevated body mass index (BMI) and a wide range of vascular and cardiometabolic diseases in men and women.</p><p><strong>Materials and methods: </strong>This retrospective cohort study used data from the IQVIA Disease Analyzer database, comprising anonymized records from over 3000 office-based physicians in Germany. We included 233 730 patients aged ≥40 years with at least one recorded BMI measurement between January 2005 and December 2023. Fourteen vascular and cardiovascular conditions were identified using ICD-10 codes. Ten-year cumulative incidence was estimated using the Kaplan-Meier method, and Cox regression models assessed associations between BMI groups and disease risk.</p><p><strong>Results: </strong>Obesity was associated with higher risks of heart failure (HR: 1.95; 95% CI: 1.85-2.05), pulmonary embolism (HR: 1.83; 95% CI: 1.62-2.07), atrial fibrillation/flutter (HR: 1.63; 95% CI: 1.55-1.72), phlebitis/vein thrombosis (HR: 1.60; 95% CI: 1.51-1.70), varicose veins of the lower extremities (HR: 1.57; 95% CI: 1.51-1.64), angina pectoris (HR: 1.30; 95% CI: 1.21-1.41), and myocardial infarction (HR: 1.26; 95% CI: 1.15-1.38), but a lower risk of haemorrhagic stroke (HR: 0.76; 95% CI: 0.62-0.93). Sex-specific analyses revealed stronger associations in men for heart failure, angina pectoris, and atrial fibrillation, while women showed stronger links to pulmonary embolism, phlebitis/vein thrombosis, myocardial infarction, and varicose veins. Notably, obesity was associated with a 26% lower risk of aortic aneurysm (thoracic or abdominal) in women, with no significant effect in men.</p><p><strong>Conclusions: </strong>Obesity is associated with an increased risk of vascular and cardiometabolic diseases. The strength and direction of associations show some variation between men and women, but these tendencies should be interpreted with caution.</p>","PeriodicalId":158,"journal":{"name":"Diabetes, Obesity & Metabolism","volume":" ","pages":""},"PeriodicalIF":5.7000,"publicationDate":"2025-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes, Obesity & Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/dom.70104","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Aims: To examine the association between elevated body mass index (BMI) and a wide range of vascular and cardiometabolic diseases in men and women.
Materials and methods: This retrospective cohort study used data from the IQVIA Disease Analyzer database, comprising anonymized records from over 3000 office-based physicians in Germany. We included 233 730 patients aged ≥40 years with at least one recorded BMI measurement between January 2005 and December 2023. Fourteen vascular and cardiovascular conditions were identified using ICD-10 codes. Ten-year cumulative incidence was estimated using the Kaplan-Meier method, and Cox regression models assessed associations between BMI groups and disease risk.
Results: Obesity was associated with higher risks of heart failure (HR: 1.95; 95% CI: 1.85-2.05), pulmonary embolism (HR: 1.83; 95% CI: 1.62-2.07), atrial fibrillation/flutter (HR: 1.63; 95% CI: 1.55-1.72), phlebitis/vein thrombosis (HR: 1.60; 95% CI: 1.51-1.70), varicose veins of the lower extremities (HR: 1.57; 95% CI: 1.51-1.64), angina pectoris (HR: 1.30; 95% CI: 1.21-1.41), and myocardial infarction (HR: 1.26; 95% CI: 1.15-1.38), but a lower risk of haemorrhagic stroke (HR: 0.76; 95% CI: 0.62-0.93). Sex-specific analyses revealed stronger associations in men for heart failure, angina pectoris, and atrial fibrillation, while women showed stronger links to pulmonary embolism, phlebitis/vein thrombosis, myocardial infarction, and varicose veins. Notably, obesity was associated with a 26% lower risk of aortic aneurysm (thoracic or abdominal) in women, with no significant effect in men.
Conclusions: Obesity is associated with an increased risk of vascular and cardiometabolic diseases. The strength and direction of associations show some variation between men and women, but these tendencies should be interpreted with caution.
期刊介绍:
Diabetes, Obesity and Metabolism is primarily a journal of clinical and experimental pharmacology and therapeutics covering the interrelated areas of diabetes, obesity and metabolism. The journal prioritises high-quality original research that reports on the effects of new or existing therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems. ‘Metabolism’ may relate to lipids, bone and drug metabolism, or broader aspects of endocrine dysfunction. Preclinical pharmacology, pharmacokinetic studies, meta-analyses and those addressing drug safety and tolerability are also highly suitable for publication in this journal. Original research may be published as a main paper or as a research letter.